Summary, detailed information, and eligibility requirements for this National Institutes of Health clinical trial to evaluate the efficiency, safety, and doses of a new spray treatment.
Aims to answer the question: What is the best way to prevent the recurrence of blood clots in the legs and lungs? Features background information about thrombosis and its treatment plus information about the trial and patient eligibility.
Abstract of a New England Journal of Medicine article detailing the results of the PREVENT clinical trial. [Paid registration required to view full article]